Nephrocalcinosis, renal dysfunction and calculi in patients with primary hypoparathyroidism on long-term conventional therapy
Journal of Clinical Endocrinology and Metabolism Jan 12, 2020
Saha S, et al. - In order to find out nephrocalcinosis, renal dysfunction and calculi, their predictors and progression over long-term follow-up in individuals with primary hypoparathyroidism (PH), researchers conducted an observational study of 165 hypoparathyroid participants at tertiary-care center. By radiographs, USG and CT, hypoparathyroid individuals receiving conventional therapy were investigated. They assessed glomerular-filtration rate (GFR) by Tc-99m-diethylenetriamine penta-acetic acid clearance. They noted nephrocalcinosis in 6.7% of hypoparathyroid patients but not in controls. Nephrocalcinosis was developed in 6.7% of patients with primary hypoparathyroidism and 14% indicated renal dysfunction. There was similar frequency of renal calculi in patients and controls. Nephrocalcinosis was found in 9.0% of patients over 10 years of conventional therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries